Affimer

A type of synthetic protein used in biotechnology and medicine

Affimers are a class of synthetic proteins that are engineered to bind to specific target molecules. They are used in a variety of biotechnology and medical applications, including diagnostics, therapeutics, and research. Affimers are an alternative to antibodies and have several advantages, such as stability, ease of production, and the ability to bind to a wide range of targets.

Structure and Function

Affimers are based on a small protein scaffold, typically derived from cysteine protease inhibitors or staphylococcal protein A. This scaffold is engineered to display a variable region that can be tailored to bind specific target molecules with high affinity and specificity. The small size and simple structure of affimers allow them to be produced in bacterial systems, making them cost-effective and scalable.

Applications

Affimers have a wide range of applications in the field of biotechnology and medicine:

Diagnostics

In diagnostics, affimers are used as biorecognition elements in biosensors and immunoassays. They can be engineered to detect specific biomarkers associated with diseases, providing a tool for early diagnosis and monitoring of disease progression.

Therapeutics

Affimers are being explored as therapeutic agents due to their ability to specifically target and modulate the activity of proteins involved in disease processes. They can be used to inhibit protein-protein interactions or to deliver therapeutic payloads to specific cells or tissues.

Research

In research, affimers are used as tools to study protein function and interactions. They can be used to isolate and purify proteins, to visualize proteins in cells, and to modulate protein activity in cellular and animal models.

Advantages over Antibodies

Affimers offer several advantages over traditional antibodies:

• Stability: Affimers are more stable than antibodies, making them suitable for use in harsh conditions.
• Production: They can be produced in bacterial systems, which is faster and more cost-effective than the production of antibodies in mammalian cells.
• Versatility: Affimers can be engineered to bind a wide range of targets, including those that are difficult for antibodies to recognize.

Development and Engineering

The development of affimers involves the selection of a suitable scaffold and the engineering of the variable region to achieve the desired binding properties. This process often involves phage display or other combinatorial library techniques to screen for affimers with high affinity and specificity for the target molecule.

Related pages

• Antibody
• Protein engineering
• Biotechnology
• Therapeutic protein

Gallery

• Diagram of an Affimer structure
  Diagram of an Affimer structure